The overstimulation of acetylcholinesterase (AChE) can cause a decline in ACh levels, leading to the frequent prescription of AChE inhibitors (AChEIs), such as tacrine (TA), as useful drugs to treat cognitive impairments in dementia patients [8]. This evidence concerns the gene ACHE and Cognitive impairment.